(Q51813446)

English

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

1 reference

based on heuristic

inferred from title

Richard E Champlin

11

object named as

Champlin RE

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

7

object named as

Giralt SA

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

author name string

Ueno NT

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Konoplev S

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Buchholz TA

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Smith T

4

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Rondón G

5

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Anderlini P

6

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Gajewski JL

8

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Donato ML

9

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Cristofanilli M

10

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Bone Marrow Transplantation

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

37

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

10

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

929-935

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705355

0 references

Update on the management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

21 January 2018

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705355

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705355

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/16565737

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51813446&oldid=1809620297"